155 related articles for article (PubMed ID: 26991787)
41. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
Ramos-Vara JA; Frank CB; DuSold D; Miller MA
J Comp Pathol; 2016 Nov; 155(4):286-298. PubMed ID: 27567273
[TBL] [Abstract][Full Text] [Related]
43. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
[TBL] [Abstract][Full Text] [Related]
44. [Clinicopathologic characteristics and histogenesis of mucinous tumor of peritoneum].
Zhang H; Sun Y; Huang X; Jia L; Bai Y; Cao D
Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):163-8. PubMed ID: 24842014
[TBL] [Abstract][Full Text] [Related]
45. Napsin A is differentially expressed in sclerosing hemangiomas of the lung.
Schmidt LA; Myers JL; McHugh JB
Arch Pathol Lab Med; 2012 Dec; 136(12):1580-4. PubMed ID: 23194051
[TBL] [Abstract][Full Text] [Related]
46. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
Groisman GM; Meir A; Sabo E
Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551
[TBL] [Abstract][Full Text] [Related]
47. Metastatic adenocarcinoma to the brain: an immunohistochemical approach.
Perry A; Parisi JE; Kurtin PJ
Hum Pathol; 1997 Aug; 28(8):938-43. PubMed ID: 9269830
[TBL] [Abstract][Full Text] [Related]
48. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.
Yun SP; Seo HI
BMC Gastroenterol; 2015 Nov; 15():165. PubMed ID: 26603157
[TBL] [Abstract][Full Text] [Related]
49. Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status.
Lugli A; Tzankov A; Zlobec I; Terracciano LM
Mod Pathol; 2008 Nov; 21(11):1403-12. PubMed ID: 18587323
[TBL] [Abstract][Full Text] [Related]
50. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas.
Gyure KA; Morrison AL
Mod Pathol; 2000 Jun; 13(6):638-43. PubMed ID: 10874668
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H
Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611
[TBL] [Abstract][Full Text] [Related]
52. Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
Peat TJ; Edmondson EF; Miller MA; DuSold DM; Ramos-Vara JA
Vet Pathol; 2017 Jul; 54(4):588-594. PubMed ID: 28346124
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemistry of Cytokeratin 7, Cytokeratin 20 and Thyroid Transcription Factor-1 in Metastatic Carcinoma of Cervical Lymph Node Biopsy for Identification of Pulmonary Origin in Rajavithi Hospital.
Kuakpaetoon T
J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S172-6. PubMed ID: 29927559
[TBL] [Abstract][Full Text] [Related]
54. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
[TBL] [Abstract][Full Text] [Related]
55. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958
[TBL] [Abstract][Full Text] [Related]
56. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W
Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119
[TBL] [Abstract][Full Text] [Related]
57. Cytokeratin 7 and 20 as immunohistochemical markers in identification of primary tumors in craniospinal metastases: do they have a significant role?
Taweevisit M; Isarakul P; Chaipipat M; Keetacheeva K; Wattanasirmkit V; Shuangshoti S
Neuropathology; 2003 Dec; 23(4):271-4. PubMed ID: 14719541
[TBL] [Abstract][Full Text] [Related]
58. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.
Jones TD; Kernek KM; Yang XJ; Lopez-Beltran A; MacLennan GT; Eble JN; Lin H; Pan CX; Tretiakova M; Baldridge LA; Cheng L
Hum Pathol; 2005 Jul; 36(7):718-23. PubMed ID: 16084939
[TBL] [Abstract][Full Text] [Related]
59. Cytokeratin CK 7 and CK 20 expression in pituitary adenomas.
Coons SW; Estrada SI; Gamez R; White WL
Endocr Pathol; 2005; 16(3):201-10. PubMed ID: 16299403
[TBL] [Abstract][Full Text] [Related]
60. The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease.
Perrotto J; Abbott JJ; Ceilley RI; Ahmed I
Am J Dermatopathol; 2010 Apr; 32(2):137-43. PubMed ID: 20051815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
